EN DE
STOCK COMPARISON

Runben Biotechnology Co Ltd Ordinary Shares - Class A vs Procter & Gamble: Fair Value & Quality

Both stocks run through our valuation models. Here is how Runben Biotechnology Co Ltd Ordinary Shares - Class A (603193) and Procter & Gamble (PG) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees Procter & Gamble as the less overvalued of the two: Runben Biotechnology Co Ltd Ordinary Shares - Class A trades at ¥20.79 versus a fair value of ¥13.21 (-36%), while Procter & Gamble trades at $146 versus $108 (-26%).
Runben Biotechnology Co Ltd Ordinary Shares - Class A
603193.SHG · CNY · Consumer Defensive
-36%
upside to fair value
overvalued
Price¥20.79
Fair Value¥13.21
Quality60/100
Procter & Gamble
PG · USD · Consumer Staples
-26%
upside to fair value
overvalued
Price$146
Fair Value$108
Quality75/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Runben Biotechnology Co Ltd Ordinary Shares - Class AProcter & Gamble
Valuation
27.0×P/E (TTM)21.5×
5.56×P/S (TTM)3.95×
3.93×P/B6.58×
24.0×EV/EBITDA14.3×
—PEG4.13×
2.1%Dividend yield2.9%
¥0.46Dividend per share$4.23
Profitability
21%Net margin19%
19%Operating margin23%
15%Return on equity31%
9%Return on assets11%
Growth
11%Revenue growth (YoY)7%
21.7%Avg. growth/yr (3Y)1.7%
28.4%Avg. growth/yr (5Y)3.5%
Balance & size
—Debt / equity0.48×
$1BMarket cap$342B
healthyGrowth qualityhealthy

Procter & Gamble leads: 5 to 7 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Runben Biotechnology Co Ltd Ordinary Shares - Class Aof which business quality 61 · market factors 31 Procter & Gambleof which business quality 71 · market factors 54
ProfitabilityMargins and returns on capital today
67
73
Quality GrowthAre margins and returns improving?
66
46
CashflowEarnings quality: real cash, not paper profit
51
65
Fin. StrengthBalance sheet, leverage, solvency risk
85
70
InvestmentDisciplined investing over empire-building
27
85
Low VolatilityCalm price path (market factor)
76
95
MomentumPrice trend over the last 3–12 months (market factor)
17
40
52W MomentumDistance to the 52-week high (market factor)
2
33
Net IssuanceBuybacks instead of dilution
52
91

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Runben Biotechnology Co Ltd Ordinary Shares - Class A

DCF Models¥18.17
Earnings-Based¥21.50
Dividend Discount¥7.11
Multiples¥12.55
Asset-Based¥3.68
Growth DCF¥14.21
Economic Profit¥8.79
Growth Earnings¥26.43

20 of 26 models see the stock below the current price.

Procter & Gamble

DCF Models$97.73
Earnings-Based$85.21
Dividend Discount$59.55
Multiples$120
Asset-Based$14.97
Growth DCF$74.21
Economic Profit$68.20
Growth Earnings$112

24 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Runben Biotechnology Co Ltd Ordinary Shares - Class A
Bear ¥9.32Fair Value ¥13.21Bull ¥16.86
¥20.79 = current price (white tick)
Procter & Gamble
Bear $70.77Fair Value $108Bull $151
$146 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Runben Biotechnology Co Ltd Ordinary Shares - Class A · Consumer Defensive

Quality score60 · above median
Fair value upside-36% · below median

Procter & Gamble · Consumer Staples

Quality score75 · Top 25%
Fair value upside-26% · below median

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees Procter & Gamble as the less overvalued of the two: Runben Biotechnology Co Ltd Ordinary Shares - Class A trades at ¥20.79 versus a fair value of ¥13.21 (-36%), while Procter & Gamble trades at $146 versus $108 (-26%).

Procter & Gamble has the higher quality score (75/100).

See the full analysis →
Runben Biotechnology Co Ltd Ordinary Shares - Class A · Procter & Gamble

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Runben Biotechnology Co Ltd Ordinary Shares - Class A

Alphabet Inc Class C vs Verizon CommunicationsAlphabet Inc Class C vs At&tAlphabet Inc Class C vs NetEaseAmazon.com vs Toyota Motor Corporation

Related to Procter & Gamble

Procter & Gamble vs AltriaWalmart vs AltriaCostco Wholesale vs AltriaCoca-Cola vs Altria
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.